Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules
Masha J. Livhits, Catherine Zhu, Eric J. Kuo, et al.
JAMA Oncology (2020) Vol. 7, Iss. 1, pp. 70-70
Open Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

Diagnosis of thyroid nodules
Erik K. Alexander, Edmund S. Cibas
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 7, pp. 533-539
Closed Access | Times Cited: 132
Application of machine learning-assisted surface-enhanced Raman spectroscopy in medical laboratories: principles, opportunities, and challenges
Jia-Wei Tang, Quan Yuan, Li Zhang, et al.
TrAC Trends in Analytical Chemistry (2025), pp. 118135-118135
Closed Access | Times Cited: 6
Contemporary Management of Thyroid Nodules
Kristen Kobaly, Caroline S. Kim, Susan J. Mandel
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 517-528
Closed Access | Times Cited: 75
Artificial intelligence defines protein-based classification of thyroid nodules
Yaoting Sun, Sathiyamoorthy Selvarajan, Zelin Zang, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 47
Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022]
Barbara Jarząb, Marek Dedecjus, Andrzej Lewiński, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 2, pp. 173-300
Open Access | Times Cited: 40
Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management
Simion I. Chiosea, Steven P. Hodak, Linwah Yip, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 11, pp. 2999-3008
Open Access | Times Cited: 33
Molecular diagnostics in the evaluation of thyroid nodules: Current use and prospective opportunities
Jena Patel, Joshua Klopper, Elizabeth Cottrill
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 32
Thyroid nodules: diagnosis and management
Giorgio Grani, Marialuisa Sponziello, Sébastiano Filetti, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 12, pp. 715-728
Closed Access | Times Cited: 9
High Rates of Unnecessary Surgery for Indeterminate Thyroid Nodules in the Absence of Molecular Test and the Cost-Effectiveness of Utilizing Molecular Test in an Asian Population: A Decision Analysis
Matrix Man Him Fung, Ching Tang, Gin Wai Kwok, et al.
Thyroid (2025)
Closed Access | Times Cited: 1
Thyroid Nodule Characterization: How to Assess the Malignancy Risk. Update of the Literature
Daniele Fresilli, Emanuele David, Patrizia Pacini, et al.
Diagnostics (2021) Vol. 11, Iss. 8, pp. 1374-1374
Open Access | Times Cited: 53
Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules
Mimi I. Hu, Steven G. Waguespack, Chrysoula Dosiou, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 8, pp. 2198-2207
Open Access | Times Cited: 49
Thyroid Nodule Evaluation and Management in Older Adults: A Review of Practical Considerations for Clinical Endocrinologists
Naykky Singh Ospina, Maria Papaleontiou
Endocrine Practice (2021) Vol. 27, Iss. 3, pp. 261-268
Open Access | Times Cited: 47
Molecular Genetics of Follicular-Derived Thyroid Cancer
Elisabetta Macerola, Anello Marcello Poma, Paola Vignali, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 1139-1139
Open Access | Times Cited: 45
An eXplainable Artificial Intelligence analysis of Raman spectra for thyroid cancer diagnosis
Loredana Bellantuono, R. Tommasi, Ester Pantaleo, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Bethesda III and IV Thyroid Nodules Managed Nonoperatively After Molecular Testing With Afirma GSC or Thyroseq v3
Na Eun Kim, Rajam Raghunathan, Elena G Hughes, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 9, pp. e698-e703
Open Access | Times Cited: 19
Prognostic Value of Preoperative Molecular Testing and Implications for Initial Surgical Management in Thyroid Nodules Harboring Suspected (Bethesda V) or Known (Bethesda VI) Papillary Thyroid Cancer
Max A. Schumm, Michelle L. Shu, Elena G Hughes, et al.
JAMA Otolaryngology–Head & Neck Surgery (2023) Vol. 149, Iss. 8, pp. 735-735
Closed Access | Times Cited: 17
Does the Adoption of Molecular Testing Cause Decreased Thyroidectomy Rates in a National Cohort? A Quasiexperimental Study of High- Versus Low-Adoption States
Yongmei Huang, Stephanie J. Chan, Jason D. Wright, et al.
Thyroid (2024) Vol. 34, Iss. 3, pp. 388-398
Closed Access | Times Cited: 7
Assessment of the risk of malignancy in Bethesda III thyroid nodules: a comprehensive review
Karthik Rao, Gregory W. Randolph, Fernando López, et al.
Endocrine (2024) Vol. 85, Iss. 2, pp. 473-492
Closed Access | Times Cited: 6
Integrated metabolic and genetic analysis reveals distinct features of human differentiated thyroid cancer
Eduardo Cararo Lopes, Akshada Sawant, Dirk F. Moore, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 13
Outcomes of Cytologically Indeterminate Thyroid Nodules Managed With Genomic Sequencing Classifier
Sara Ahmadi, Anupam Kotwal, Athanasios Bikas, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 12, pp. e2231-e2239
Open Access | Times Cited: 5
The Effect Modification of Ultrasound Risk Classification on Molecular Testing in Predicting the Risk of Malignancy in Cytologically Indeterminate Thyroid Nodules
Theodore Hu, Dalena T. Nguyen, Maitraya Patel, et al.
Thyroid (2022) Vol. 32, Iss. 8, pp. 905-916
Closed Access | Times Cited: 20
Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)—A Meta-analysis
Christian Nasr, Massimiliano Andrioli, Mayumi Endo, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 6, pp. 1526-1532
Open Access | Times Cited: 19
Clinical use of Molecular Data in Thyroid Nodules and Cancer
Ali S. Alzahrani
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 11, pp. 2759-2771
Closed Access | Times Cited: 12
Circulating small extracellular vesicle-based miRNA classifier for follicular thyroid carcinoma: a diagnostic study
Genpeng Li, Hongke Wang, Jinjing Zhong, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 6, pp. 925-933
Closed Access | Times Cited: 4
Ultrasonographic predictors of thyroid cancer in Bethesda III and IV thyroid nodules
Ebtihal Y. Alyusuf, Lama Alhmayin, Eman Albasri, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top